[General principles and new trends of cytostatic tumor therapy].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011034:Podophyllotoxin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D011929:Razoxane / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D011838:Radiation-Sensitizing Agents; D011929:Razoxane; D003606:Dacarbazine; D004317:Doxorubicin; D011034:Podophyllotoxin; D002945:Cisplatin
Allgemeine Prinzipien und neue Entwicklungen der zytostatischen Tumortherapie.